retatrutide type 2 diabetes phase 2 results 2024 ada trial demonstrate benefits of in obesity, diabetes, NASH Retatrutide Phase 2: Type 2

Beauty standards were set by supermodels, and society's obsession with being thin birthed the hip-hugging low-rise jeans of Y2K

If you typically eat when stressed, bored, or celebrating, those triggers may persist even as physical appetite diminishes

There is currently no established causal relationship between semaglutide use and kidney stone formation based on available clinical evidence

10.1007/s00125-009-1515-4 24 NauckM

In humans, GLP-1 is not only damaged by DPP-4, but also by neutral endopeptidase 24.11 (NEP 24.11), and the main catalytic sites are Glu 27 Phe 28 and Trp 31 Leu 32

Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have recently received Food and Drug Administration (FDA) approval for obesity management